Russell Investments Group
PRCT icon

Russell Investments Group’s Procept Biorobotics PRCT Stock Holding History

Russell Investments Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$476K Buy
21,091
+12,838
+156% +$321K ﹤0.01% 2810
2026
Q1 		$206K Buy
8,253
+1,140
+16% +$32.1K ﹤0.01% 2843
2025
Q4 		$224K Buy
7,113
+2,753
+63% +$91.3K ﹤0.01% 2808
2025
Q3 		$156K Sell
4,360
-61,155
-93% -$2.79M ﹤0.01% 2886
2025
Q2 		$3.77M Buy
65,515
+20,567
+46% +$1.16M ﹤0.01% 1383
2025
Q1 		$2.62M Buy
44,948
+44,912
+124,756% +$3.07M ﹤0.01% 1543
2024
Q4 		$2.9K Buy
36
+15
+71% +$1.28K ﹤0.01% 3377
2024
Q3 		$1.68K Buy
21
+9
+75% +$639 ﹤0.01% 3404
2024
Q2 		$733 Buy
+12
New +$714 ﹤0.01% 3467
2023
Q1 		– Sell
-135,572
Closed -$5.63M – 3364
2022
Q4 		$5.63M Buy
135,572
+133,852
+7,782% +$5.75M 0.01% 1032
2022
Q3 		$71K Buy
+1,720
New +$68.6K ﹤0.01% 2714

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Russell Investments Group's PRCT Position: Q2 2026 in Review

Russell Investments Group increased its Procept Biorobotics (PRCT) stake by 156% in Q2 2026, buying an estimated $321K and bringing the position to 21,091 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #2810.

Russell Investments Group first reported a position in PRCT in Q3 2022 and has held it in 11 quarters since. The position peaked at $5.63M in Q4 2022. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Russell Investments Group held 21,091 shares of Procept Biorobotics worth $476K as of Q2 2026.
  • Russell Investments Group bought 12,838 Procept Biorobotics shares in Q2 2026, an estimated $321K.
  • Procept Biorobotics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2810 holding.
  • Russell Investments Group first reported a position in Procept Biorobotics in Q3 2022 and has held it in 11 quarters since.
  • Russell Investments Group's Procept Biorobotics position peaked at $5.63M in Q4 2022.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.